China Cord Blood Corp (CO)

[steeledge]

That acquisition seems like a great move on CO's part. Getting access to a 3rd region seems to pave the way for CO to continue becoming THE major cord-blood player in China. It's also shrewd for them to negotiate first-refusal on potential dilution or equity ownership changes...sounds like CO will ultimately end up owning a majority of SCBB at some point in the future.

The warrants are getting into an attractive price zone with the light-volume decline of CO providing the opportunity.